Selected article for: "antiviral treatment and clinical outcome"

Author: Hao Zhou; Wanxin Chen; Ziping Li; Bohan Yang; Qiong Zhou; Ping Wang; Jianhua Zhu; Xuexing Chen; Peng Yang
Title: Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19)
  • Document date: 2020_4_15
  • ID: 2my86ums_55
    Snippet: Compared to those without delayed-phase thrombocytopenia, COVID-19 patients with delayed-phase thrombocytopenia have a longer hospital stay time and a worse clinical outcome. The present descriptive data suggested an association between delayed-phase thrombocytopenia and antiviral immune, which highlight rationality for immunoregulatory treatment. Our results encourage further research evaluating the prevalence, incidence, All rights reserved. No.....
    Document: Compared to those without delayed-phase thrombocytopenia, COVID-19 patients with delayed-phase thrombocytopenia have a longer hospital stay time and a worse clinical outcome. The present descriptive data suggested an association between delayed-phase thrombocytopenia and antiviral immune, which highlight rationality for immunoregulatory treatment. Our results encourage further research evaluating the prevalence, incidence, All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antiviral immune and incidence prevalence: 1
    • antiviral immune and stay time: 1
    • bad clinical outcome and clinical outcome: 1
    • clinical outcome and incidence prevalence: 1, 2
    • clinical outcome and long hospital: 1, 2, 3, 4, 5, 6, 7
    • clinical outcome and stay time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24